SCIENTURE HOLDINGS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
SCIENTURE HOLDINGS, INC. (SCNX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $79.07 million as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2025-03-26
- 2024-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $79.07M.
- 2024-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $85.13M.
- 2024-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.79M.
- 2024-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.62M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2024-12-31 | $79.07M 10-K · filed 2025-03-26 |
| 2024-09-30 | $85.13M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $11.79M 10-Q · filed 2024-11-06 |
| 2024-03-31 | $13.62M 10-Q · filed 2024-11-06 |
| 2023-12-31 | $542.35K 10-K · filed 2025-03-26 |
| 2023-09-30 | $11.56M 10-Q · filed 2024-11-06 |
| 2023-06-30 | -$1.29M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $655.14K 10-Q · filed 2024-11-06 |
| 2022-12-31 | $342.87K 10-K · filed 2025-03-26 |
| 2022-09-30 | $1.36M 10-Q · filed 2024-01-16 |
| 2022-06-30 | $1.80M 10-Q · filed 2024-01-16 |
| 2022-03-31 | $2.89M 10-Q · filed 2024-01-16 |
| 2021-12-31 | $3.77M 10-K · filed 2024-04-22 |
| 2021-09-30 | $4.62M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $5.79M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $8.20M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $8.68M 10-K · filed 2023-03-27 |
| 2017-12-31 | -$311.93K 10-K · filed 2018-03-02 |
| 2016-12-31 | -$1.15M 10-K · filed 2018-03-02 |
| 2015-12-31 | $267.02K 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |